These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 25568794)
1. Antibiotic management of complicated intra-abdominal infections in adults: The Asian perspective. Kurup A; Liau KH; Ren J; Lu MC; Navarro NS; Farooka MW; Usman N; Destura RV; Sirichindakul B; Tantawichien T; Lee CK; Solomkin JS Ann Med Surg (Lond); 2014 Sep; 3(3):85-91. PubMed ID: 25568794 [TBL] [Abstract][Full Text] [Related]
2. Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan. Lau YJ; Chen YH; Huang CT; Lee WS; Liu CY; Liu JW; Liu HD; Lee YJ; Chen CW; Ko WC; Hsueh PR J Microbiol Immunol Infect; 2012 Feb; 45(1):1-6. PubMed ID: 22244019 [TBL] [Abstract][Full Text] [Related]
3. Current strategies for the treatment of complicated intraabdominal infections. Skrupky LP; Tellor BR; Mazuski JE Expert Opin Pharmacother; 2013 Oct; 14(14):1933-47. PubMed ID: 23876130 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013. Chang YT; Coombs G; Ling T; Balaji V; Rodrigues C; Mikamo H; Kim MJ; Rajasekaram DG; Mendoza M; Tan TY; Kiratisin P; Ni Y; Barry W; Xu Y; Chen YH; Hsueh PR Int J Antimicrob Agents; 2017 Jun; 49(6):734-739. PubMed ID: 28435019 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Hsueh PR; Badal RE; Hawser SP; Hoban DJ; Bouchillon SK; Ni Y; Paterson DL; Int J Antimicrob Agents; 2010 Nov; 36(5):408-14. PubMed ID: 20728316 [TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections. Chen CW; Ming CC; Ma CJ; Shan YS; Yeh YS; Wang JY Surg Infect (Larchmt); 2013 Aug; 14(4):389-96. PubMed ID: 23859673 [TBL] [Abstract][Full Text] [Related]
8. Source Control and Antibiotics in Intra-Abdominal Infections. Bova R; Griggio G; Vallicelli C; Santandrea G; Coccolini F; Ansaloni L; Sartelli M; Agnoletti V; Bravi F; Catena F Antibiotics (Basel); 2024 Aug; 13(8):. PubMed ID: 39200076 [TBL] [Abstract][Full Text] [Related]
9. Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment. Silva-Nunes J; Cardoso T BMC Infect Dis; 2019 Nov; 19(1):980. PubMed ID: 31752716 [TBL] [Abstract][Full Text] [Related]
10. Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections. Lin SY; Huang CH; Ko WC; Chen YH; Hsueh PR Expert Opin Pharmacother; 2016; 17(3):339-54. PubMed ID: 26610040 [TBL] [Abstract][Full Text] [Related]
11. Epidemiological study of community- and hospital-acquired intraabdominal infections. Zhang S; Huang W Chin J Traumatol; 2015; 18(2):84-9. PubMed ID: 26511299 [TBL] [Abstract][Full Text] [Related]
12. Management of Intra-abdominal Infections due to Carbapenemase-Producing Organisms. Di Carlo P; Vitale F; O'Súilleabháin C; Casuccio A Curr Infect Dis Rep; 2014 Oct; 16(10):428. PubMed ID: 25129116 [TBL] [Abstract][Full Text] [Related]
13. Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use. Sartelli M; Tascini C; Coccolini F; Dellai F; Ansaloni L; Antonelli M; Bartoletti M; Bassetti M; Boncagni F; Carlini M; Cattelan AM; Cavaliere A; Ceresoli M; Cipriano A; Cortegiani A; Cortese F; Cristini F; Cucinotta E; Dalfino L; De Pascale G; De Rosa FG; Falcone M; Forfori F; Fugazzola P; Gatti M; Gentile I; Ghiadoni L; Giannella M; Giarratano A; Giordano A; Girardis M; Mastroianni C; Monti G; Montori G; Palmieri M; Pani M; Paolillo C; Parini D; Parruti G; Pasero D; Pea F; Peghin M; Petrosillo N; Podda M; Rizzo C; Rossolini GM; Russo A; Scoccia L; Sganga G; Signorini L; Stefani S; Tumbarello M; Tumietto F; Valentino M; Venditti M; Viaggi B; Vivaldi F; Zaghi C; Labricciosa FM; Abu-Zidan F; Catena F; Viale P World J Emerg Surg; 2024 Jun; 19(1):23. PubMed ID: 38851757 [TBL] [Abstract][Full Text] [Related]
14. A Proposal for a Classification Guiding the Selection of Appropriate Antibiotic Therapy for Intra-Abdominal Infections. Sartelli M; Cristini F; Coccolini F; Labricciosa FM; Siquini W; Catena F Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290052 [TBL] [Abstract][Full Text] [Related]
17. Duration of Antimicrobial Therapy in Treating Complicated Intra-Abdominal Infections: A Comprehensive Review. Sartelli M; Catena F; Ansaloni L; Coccolini F; Di Saverio S; Griffiths EA Surg Infect (Larchmt); 2016 Feb; 17(1):9-12. PubMed ID: 26468904 [TBL] [Abstract][Full Text] [Related]
18. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. Sartelli M; Chichom-Mefire A; Labricciosa FM; Hardcastle T; Abu-Zidan FM; Adesunkanmi AK; Ansaloni L; Bala M; Balogh ZJ; Beltrán MA; Ben-Ishay O; Biffl WL; Birindelli A; Cainzos MA; Catalini G; Ceresoli M; Che Jusoh A; Chiara O; Coccolini F; Coimbra R; Cortese F; Demetrashvili Z; Di Saverio S; Diaz JJ; Egiev VN; Ferrada P; Fraga GP; Ghnnam WM; Lee JG; Gomes CA; Hecker A; Herzog T; Kim JI; Inaba K; Isik A; Karamarkovic A; Kashuk J; Khokha V; Kirkpatrick AW; Kluger Y; Koike K; Kong VY; Leppaniemi A; Machain GM; Maier RV; Marwah S; McFarlane ME; Montori G; Moore EE; Negoi I; Olaoye I; Omari AH; Ordonez CA; Pereira BM; Pereira Júnior GA; Pupelis G; Reis T; Sakakhushev B; Sato N; Segovia Lohse HA; Shelat VG; Søreide K; Uhl W; Ulrych J; Van Goor H; Velmahos GC; Yuan KC; Wani I; Weber DG; Zachariah SK; Catena F World J Emerg Surg; 2017; 12():29. PubMed ID: 28702076 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. Chen YH; Hsueh PR; Badal RE; Hawser SP; Hoban DJ; Bouchillon SK; Ni Y; Paterson DL J Infect; 2011 Apr; 62(4):280-91. PubMed ID: 21382411 [TBL] [Abstract][Full Text] [Related]
20. Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections. Eckmann C; Solomkin J Expert Opin Pharmacother; 2015 Feb; 16(2):271-80. PubMed ID: 25529765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]